NCT02631746 2025-03-14Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/LymphomaNational Cancer Institute (NCI)Phase 2 Completed3 enrolled 8 charts
NCT03226119 2018-09-13MP Diagnostics HTLV Blot 2.4 Post-Market Clinical StudyMP Biomedicals, LLCPhase 4 Completed150 enrolled
NCT03146013 2017-06-12Dual Algorithm Post Market Clinical StudyMP Biomedicals, LLCCompleted100 enrolled